Health insurer Horizon Blue Cross Blue Shield of New Jersey, has entered into a two-year collaboration with Hackensack University Medical Center, its physicians, and the VeriChip Corporation to implant FDA-approved microchips in chronically ill patients, enabling emergency room physicians to access their medical records electronically.
The microchips provide immediate access to family contact information and information about the patients’ medical histories and health insurance claim data that could prove vital in an emergency.
Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) will make the new VeriChip-developed technology available to select members with chronic conditions. Those members who participate in the program will agree to have an implantable radio frequency identification (RFID) device placed under their skin.
VeriChip calls the RFID a personal health record module. The information on the module will include medical information from Horizon BCBSNJ’s claim records, such as lab test data and pharmacy prescription information. This module emits a 16-digit number that links the patient to their electronic medical record when a special hand-held scanner is waved over it.